During the past decade, Park Place Therapeutic Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Park Place Therapeutic Center" are "Back Pain" (2 trials), "Chronic Pain" (2 trials), "Osteoarthritis" (1 trials) and "Postoperative Pain" (1 trials). Many other conditions were trialed in "Park Place Therapeutic Center" in a lesser frequency.

Most popular intervention types in "Park Place Therapeutic Center" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine transdermal delivery system" (3 trials), "Oxymorphone Extended Release" (2 trials), "Buprenorphine transdermal patch" (1 trials), "OXY/APAP" (1 trials) and "Placebo oxycodone/acetaminophen tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Park Place Therapeutic Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Park Place Therapeutic Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Park Place Therapeutic Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Park Place Therapeutic Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".